BDBM454514 US10717742, Example Ic-27::US10882866, Example Ic-27

SMILES CCOc1cccc(CN2[C@H]3Cc4c(nc5c(C)c(ccn45)C(O)=O)[C@H]3[C@H](c3ccnc(Cl)c3F)[C@]22C(=O)Nc3cc(Cl)ccc23)c1

InChI Key InChIKey=DTVLWGMVHOGLSO-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 454514   

TargetE3 ubiquitin-protein ligase Mdm2 [23-117](Human)
Boehringer Ingelheim International

US Patent
LigandChemical structure of BindingDB Monomer ID 454514BDBM454514(US10717742, Example Ic-27 | US10882866, Example Ic...)
Affinity DataIC50: 13nMAssay Description:15 μL of compound in 20% DMSO (serial pre-dilutions of compound are done in 100% DMSO) is pipetted to the wells of a white OptiPlate-96 (Perkin ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase Mdm2 [23-117](Human)
Boehringer Ingelheim International

US Patent
LigandChemical structure of BindingDB Monomer ID 454514BDBM454514(US10717742, Example Ic-27 | US10882866, Example Ic...)
Affinity DataIC50: 13nMAssay Description:This assay is used to determine whether the compounds inhibit the p53-MDM2 interaction and thus restore p53 function.15 μL of compound in 20% DM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/1/2021
Entry Details
US Patent